You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. BARDA and Partner Therapeutics continue partnership around development of LEUKINE® (sargramostim, rhu GM-CSF) to potentially improve patient care for sepsis
- 2. Thousands of blood cancer patients could benefit from new drug combination
- 3. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 4. Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
- 5. Diagnostic value of [18F]PSMA-1007 PET/CT based on PRIMARY score combined with mpMRI in clinically significant prostate cancer
- 6. Update in the clinical utilization of chemoprevention for breast cancer: a narrative review
- 7. Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
- 8. Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma
- 9. Effects of gut microbiota in breast cancer
- 10. Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon
Last updated at 5:32 GMT
Hot News Makers
Health/Pharma Companies
-
29582.16
-
24280.75
-
21036.56
-
17577.86
-
15843.29
-
14744.67
-
14645.97
-
14231.70
-
13308.72
-
12021.86
Drugs, Treatments, Trials
-
42841.56
-
14646.17
-
11990.92
-
9847.86
-
4970.36
-
4923.93
-
4091.31
-
3527.36
-
3518.06
-
2237.25
Last updated at 5:10 GMT
